These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11780394)

  • 41. Adenoviral mediated suicide gene transfer in the treatment of pancreatic cancer.
    Pan X; Li Z; Xu G; Cui L; Zhang S; Gong Y; Tu Z
    Chin Med J (Engl); 2002 Aug; 115(8):1205-8. PubMed ID: 12215293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Experimental studies on the treatment of colon cancer by cytosine deaminase gene and 5-fluorocytosine].
    Huang JH; Wang Y; Li CH; Zhong DG; Lü HY
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):6-8. PubMed ID: 15771788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene therapy for human hepatocellular carcinoma with cytosine deaminase gene and prodrug flucytosine.
    Lü HZ; Wu DZ; Wan YL; Gu B; Gao HZ; Liang YQ; Wang JX
    Zhongguo Yao Li Xue Bao; 1999 May; 20(5):440-4. PubMed ID: 10678093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer.
    Rowley S; Lindauer M; Gebert JF; Haberkorn U; Oberdorfer F; Moebius U; Herfarth C; Schackert HK
    J Surg Oncol; 1996 Jan; 61(1):42-8. PubMed ID: 8544459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adenoviral-mediated transfer of a heat-inducible double suicide gene into prostate carcinoma cells.
    Blackburn RV; Galoforo SS; Corry PM; Lee YJ
    Cancer Res; 1998 Apr; 58(7):1358-62. PubMed ID: 9537229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Study on the in vivo killing activity of YCD/5-FC gene therapy system on K562B cells].
    Zhang Y; Wang J; Zhou H; Zhai Y
    Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):173-5. PubMed ID: 12133450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene.
    Kanai F; Lan KH; Shiratori Y; Tanaka T; Ohashi M; Okudaira T; Yoshida Y; Wakimoto H; Hamada H; Nakabayashi H; Tamaoki T; Omata M
    Cancer Res; 1997 Feb; 57(3):461-5. PubMed ID: 9012474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect.
    Pierrefite-Carle V; Baqué P; Gavelli A; Mala M; Chazal M; Gugenheim J; Bourgeon A; Milano G; Staccini P; Rossi B
    J Natl Cancer Inst; 1999 Dec; 91(23):2014-9. PubMed ID: 10580026
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer].
    Yang Q; Yang G; Wei L; Jia F; Wu M; Guo Y
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):775-9. PubMed ID: 12126551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases.
    Humphreys MJ; Ghaneh P; Greenhalf W; Campbell F; Clayton TM; Everett P; Huber BE; Richards CA; Ford MJ; Neoptolemos JP
    Gene Ther; 2001 Aug; 8(16):1241-7. PubMed ID: 11509957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system.
    Miyagi T; Koshida K; Hori O; Konaka H; Katoh H; Kitagawa Y; Mizokami A; Egawa M; Ogawa S; Hamada H; Namiki M
    J Gene Med; 2003 Jan; 5(1):30-7. PubMed ID: 12516049
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Combined gene therapy for murine liver cancer with interleukin-18 and cytosine deaminase genes].
    Sun W; Tang Z; Wei D; Tang Y; Chen S
    Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):300-2. PubMed ID: 11676879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
    You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus.
    Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Yoshida Y; Hamada H; Ohmoto T
    Cancer Gene Ther; 2000 Jan; 7(1):74-82. PubMed ID: 10678359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer.
    Freytag SO; Khil M; Stricker H; Peabody J; Menon M; DePeralta-Venturina M; Nafziger D; Pegg J; Paielli D; Brown S; Barton K; Lu M; Aguilar-Cordova E; Kim JH
    Cancer Res; 2002 Sep; 62(17):4968-76. PubMed ID: 12208748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer.
    Li Y; McCadden J; Ferrer F; Kruszewski M; Carducci M; Simons J; Rodriguez R
    Cancer Res; 2002 May; 62(9):2576-82. PubMed ID: 11980652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antitumor activity of the 16-kDa prolactin fragment in prostate cancer.
    Kim J; Luo W; Chen DT; Earley K; Tunstead J; Yu-Lee LY; Lin SH
    Cancer Res; 2003 Jan; 63(2):386-93. PubMed ID: 12543792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Gene therapy for murine liver cancer by adenovirus-mediated cytosine deaminase gene].
    Sun W; Wei D; Tang Z; Chen S
    Zhonghua Gan Zang Bing Za Zhi; 2000 Oct; 8(5):282-4. PubMed ID: 11058952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.